Improving the treatment landscape for DLBCL patients

Improving the treatment landscape for DLBCL patients

VJHemOnc

1 year
34 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Speaking from the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Andrés Ferreri, MD, of IRCCS San Raffaele Hospital, Milan, Italy, describes the difficulties associated with treating high-risk patients with diffuse large B-cell lymphoma (DLBCL).
Up Next Autoplay